Target intelligence / Profile preview

CBARP divergent transcript (CBARP-DT)

Target
CBARP-DT
Molecular classification
Other, Long non-coding RNA (lncRNA), Divergent transcript
01

Overview

CBARP divergent transcript (CBARP-DT) is an annotated long non-coding RNA (lncRNA) transcribed antisense to, and usually upstream from, the protein-coding CBARP gene. Such divergent transcripts are a genome-wide feature linked to the regulation of nearby genes, particularly at active promoters, but typically lack protein-coding potential and are not therapeutic targets themselves[2][4][1][5][6]. The biological function of CBARP-DT specifically is unknown, and there is no evidence of involvement in disease or druggability. More broadly, divergent transcripts can play a role in transcriptional regulation and the evolution of new genes, but most remain poorly characterized and have no direct therapeutic relevance[1][4][6].\nCBARP-DT appears in gene annotation databases as a lncRNA, not as a target for drug discovery, and there is no therapeutic, mechanistic, or disease linkage for this transcript in current scientific literature or database descriptions[2][5][6].

Other names
CBARP divergent transcript
02

Biological functions

Possible gene regulation (general to divergent lncRNAs)Other (no specific characterized function for CBARP-DT itself)
03

Disease associations

None known (no evidence implicating CBARP-DT in disease; general divergent lncRNAs can be associated with gene regulation in development and disease, but not for CBARP-DT specifically)

Beyond the preview

Go deeper on CBARP divergent transcript (CBARP-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CBARP divergent transcript (CBARP-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call